Newer, Younger Fleet of Michigan Bios Try To Help Region Rebound After Pfizer Flees | GenomeWeb
One year before Pfizer completes shutting down its Ann Arbor, Mich., research campus, and eliminated nearly 2,100 jobs in the process, the region’s life-sciences industry doesn’t appear down for the count.
While the pharma giant fades into history in the region, a casualty of cost-cutting tied to the rise of generic drugs and a dearth of new profitable compunds, a parade of local therapeutics and medical device companies, as well as automotive and aerospace companies, are growing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.